Correlation Between BB Biotech and Norfolk Southern

Can any of the company-specific risk be diversified away by investing in both BB Biotech and Norfolk Southern at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Norfolk Southern into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BB Biotech AG and Norfolk Southern, you can compare the effects of market volatilities on BB Biotech and Norfolk Southern and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Norfolk Southern. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Norfolk Southern.

Diversification Opportunities for BB Biotech and Norfolk Southern

0.66

Correlation Coefficient

BB Biotech  Norfolk Southern

Poor diversification

The 3 months correlation between BBZA and Norfolk is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Norfolk Southern in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Norfolk Southern and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Norfolk Southern. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Norfolk Southern has no effect on the direction of BB Biotech i.e., BB Biotech and Norfolk Southern go up and down completely randomly.

Pair Corralation between BB Biotech and Norfolk Southern

Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the Norfolk Southern. But the stock apears to be less risky and, when comparing its historical volatility, BB Biotech AG is 1.24 times less risky than Norfolk Southern. The stock trades about -0.04 of its potential returns per unit of risk. The Norfolk Southern is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  20,398  in Norfolk Southern on October 5, 2024 and sell it today you would earn a total of  2,002  from holding Norfolk Southern or generate 9.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

BB Biotech AG  vs.  Norfolk Southern

BB Biotech AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Norfolk Southern

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Norfolk Southern has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Norfolk Southern is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with BB Biotech and Norfolk Southern

The main advantage of trading using opposite BB Biotech and Norfolk Southern positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Norfolk Southern can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Norfolk Southern will offset losses from the drop in Norfolk Southern's long position.

The idea behind BB Biotech AG and Norfolk Southern pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.